226 related articles for article (PubMed ID: 27457382)
1. Foxp3 overexpression in tumor cells predicts poor survival in oral squamous cell carcinoma.
Song JJ; Zhao SJ; Fang J; Ma D; Liu XQ; Chen XB; Wang Y; Cheng B; Wang Z
BMC Cancer; 2016 Jul; 16():530. PubMed ID: 27457382
[TBL] [Abstract][Full Text] [Related]
2. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma.
Koike K; Dehari H; Ogi K; Shimizu S; Nishiyama K; Sonoda T; Sasaki T; Sasaya T; Tsuchihashi K; Hasegawa T; Torigoe T; Hiratsuka H; Miyazaki A
PLoS One; 2020; 15(8):e0237465. PubMed ID: 32785290
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
5. Mediator of DNA damage checkpoint protein 1 (MDC1) as a prognostic marker for patients with oral squamous cell carcinoma.
Dave JH; Vora HH; Ghosh NR; Trivedi TI
J Oral Pathol Med; 2017 Apr; 46(4):253-258. PubMed ID: 28161894
[TBL] [Abstract][Full Text] [Related]
6. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
[TBL] [Abstract][Full Text] [Related]
9. ASC contributes to metastasis of oral cavity squamous cell carcinoma.
Wu CS; Chang KP; OuYang CN; Kao HK; Hsueh C; Chen LC; Cheng HY; Liang Y; Liou W; Liang CL; Chang YS
Oncotarget; 2016 Aug; 7(31):50074-50085. PubMed ID: 27367024
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of histone H3 serine 10 phosphorylation and histone H4 lysine 12 acetylation in oral squamous cell carcinoma.
Campos-Fernández E; Matsuo FS; Andrade MF; Servato JPS; Loyola AM; Cardoso SV; Siva SJ; Moraes ADS; de Faria PR
Histopathology; 2019 Jan; 74(2):227-238. PubMed ID: 30007038
[TBL] [Abstract][Full Text] [Related]
11. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients.
Wang Y; Hu H; Wang Q; Li Z; Zhu Y; Zhang W; Wang Y; Jiang H; Cheng J
Pathol Res Pract; 2017 Aug; 213(8):969-974. PubMed ID: 28554766
[TBL] [Abstract][Full Text] [Related]
12. KiSS-1 expression in oral squamous cell carcinoma and its prognostic significance.
Shin WJ; Cho YA; Kang KR; Kim JH; Hong SD; Lee JI; Hong SP; Yoon HJ
APMIS; 2016 Apr; 124(4):291-8. PubMed ID: 26809635
[TBL] [Abstract][Full Text] [Related]
13. Tumour budding evaluated in biopsy specimens is a useful predictor of prognosis in patients with cN0 early stage oral squamous cell carcinoma.
Seki M; Sano T; Yokoo S; Oyama T
Histopathology; 2017 May; 70(6):869-879. PubMed ID: 27926795
[TBL] [Abstract][Full Text] [Related]
14. Forkhead box-P3
Hussaini HM; Parachuru VPB; Seymour GJ; Rich AM
Acta Histochem; 2017 Apr; 119(3):205-210. PubMed ID: 28174027
[TBL] [Abstract][Full Text] [Related]
15. High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma.
Moura IM; Delgado ML; Silva PM; Lopes CA; do Amaral JB; Monteiro LS; Bousbaa H
J Oral Pathol Med; 2014 Mar; 43(3):225-31. PubMed ID: 24044615
[TBL] [Abstract][Full Text] [Related]
16. Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma.
Närkiö-Mäkelä M; Pukkila M; Lagerstedt E; Virtaniemi J; Pirinen R; Johansson R; Kosunen A; Lappalainen K; Hämäläinen K; Kosma VM
Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1035-40. PubMed ID: 19841345
[TBL] [Abstract][Full Text] [Related]
17. Progression level of extracapsular spread and tumor budding for cervical lymph node metastasis of OSCC.
Yamada SI; Otsuru M; Yanamoto S; Hasegawa T; Aizawa H; Kamata T; Yamakawa N; Kohgo T; Ito A; Noda Y; Hirai C; Kitamura T; Okura M; Kirita T; Ueda M; Yamashita T; Ota Y; Komori T; Umeda M; Kurita H
Clin Oral Investig; 2018 Apr; 22(3):1311-1318. PubMed ID: 28986696
[TBL] [Abstract][Full Text] [Related]
18. Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas.
Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM; Huang SF
PLoS One; 2016; 11(10):e0164870. PubMed ID: 27764170
[TBL] [Abstract][Full Text] [Related]
19. Effect of c-Met expression on survival in head and neck squamous cell carcinoma.
Lo Muzio L; Farina A; Rubini C; Coccia E; Capogreco M; Colella G; Leonardi R; Campisi G; Carinci F
Tumour Biol; 2006; 27(3):115-21. PubMed ID: 16612144
[TBL] [Abstract][Full Text] [Related]
20. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
